Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor 9 (CCR9) and anti-α4β7 integrin blocking antibodies

US Patent 10532051 · Granted Jan 14, 2020

Estimated economic value: $51,758,000

Assignee

Inventors

View full patent text on Google Patents →